Nihon Kohden (OTCMKTS:NHNKY) Sees Strong Trading Volume – Should You Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares saw an uptick in trading volume on Thursday . Approximately 28,894 shares changed hands during trading, an increase of 15% from the previous session’s volume of 25,081 shares.The stock last traded at $9.5280 and had previously closed at $9.58.

Analyst Ratings Changes

Separately, UBS Group downgraded Nihon Kohden from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 12th. Two investment analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has an average rating of “Hold”.

Nihon Kohden Trading Up 4.7%

The company has a market capitalization of $1.68 billion, a PE ratio of 18.20 and a beta of 0.36. The business’s 50-day simple moving average is $9.51 and its 200-day simple moving average is $9.41.

Nihon Kohden (OTCMKTS:NHNKY) last announced its quarterly earnings data on Thursday, August 6th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.09). The business had revenue of $297.47 million for the quarter, compared to analyst estimates of $299.98 million. Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. Sell-side analysts forecast that Nihon Kohden Corporation will post 0.6 EPS for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.